3-149177867-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000096.4(CP):​c.2991T>C​(p.His997His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0416 in 1,613,350 control chromosomes in the GnomAD database, including 1,660 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 98 hom., cov: 32)
Exomes 𝑓: 0.043 ( 1562 hom. )

Consequence

CP
NM_000096.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.990

Publications

10 publications found
Variant links:
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
CP Gene-Disease associations (from GenCC):
  • aceruloplasminemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • disorder of iron metabolism and transport
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 3-149177867-A-G is Benign according to our data. Variant chr3-149177867-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128841.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.99 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0304 (4625/152276) while in subpopulation NFE AF = 0.0441 (2997/68022). AF 95% confidence interval is 0.0427. There are 98 homozygotes in GnomAd4. There are 2290 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 98 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPNM_000096.4 linkc.2991T>C p.His997His synonymous_variant Exon 17 of 19 ENST00000264613.11 NP_000087.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPENST00000264613.11 linkc.2991T>C p.His997His synonymous_variant Exon 17 of 19 1 NM_000096.4 ENSP00000264613.6

Frequencies

GnomAD3 genomes
AF:
0.0304
AC:
4628
AN:
152158
Hom.:
99
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00965
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0201
Gnomad ASJ
AF:
0.0141
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.0305
Gnomad FIN
AF:
0.0613
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0441
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0334
AC:
8405
AN:
251326
AF XY:
0.0354
show subpopulations
Gnomad AFR exome
AF:
0.00763
Gnomad AMR exome
AF:
0.0156
Gnomad ASJ exome
AF:
0.0146
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0645
Gnomad NFE exome
AF:
0.0434
Gnomad OTH exome
AF:
0.0377
GnomAD4 exome
AF:
0.0428
AC:
62464
AN:
1461074
Hom.:
1562
Cov.:
31
AF XY:
0.0426
AC XY:
30940
AN XY:
726854
show subpopulations
African (AFR)
AF:
0.00828
AC:
277
AN:
33462
American (AMR)
AF:
0.0160
AC:
715
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
348
AN:
26126
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39684
South Asian (SAS)
AF:
0.0349
AC:
3008
AN:
86246
European-Finnish (FIN)
AF:
0.0628
AC:
3356
AN:
53412
Middle Eastern (MID)
AF:
0.0522
AC:
301
AN:
5768
European-Non Finnish (NFE)
AF:
0.0471
AC:
52357
AN:
1111288
Other (OTH)
AF:
0.0348
AC:
2098
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2849
5697
8546
11394
14243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1956
3912
5868
7824
9780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0304
AC:
4625
AN:
152276
Hom.:
98
Cov.:
32
AF XY:
0.0308
AC XY:
2290
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00965
AC:
401
AN:
41570
American (AMR)
AF:
0.0201
AC:
307
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0141
AC:
49
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.0303
AC:
146
AN:
4822
European-Finnish (FIN)
AF:
0.0613
AC:
651
AN:
10612
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0441
AC:
2997
AN:
68022
Other (OTH)
AF:
0.0274
AC:
58
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
230
459
689
918
1148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0376
Hom.:
76
Bravo
AF:
0.0267
Asia WGS
AF:
0.00664
AC:
23
AN:
3478
EpiCase
AF:
0.0412
EpiControl
AF:
0.0431

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 06, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Deficiency of ferroxidase Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
5.1
DANN
Benign
0.74
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34394958; hg19: chr3-148895654; API